This study is a prospective, single-center, single-arm pilot trial. The primary research question is whether brief, breath control-focused Acceptance and Commitment Therapy (ACT) is feasible, acceptable, and safe in adults with chronic cough.
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Recruitment rate
Timeframe: From screening and recruitment to enrollment
Retention rate
Timeframe: From enrollment to the end of treatment at 4 weeks
Adherence rate of session attendance
Timeframe: From enrollment to the end of treatment at 4 weeks
Ordinal scale of adherence to self-directed activities
Timeframe: From enrollment to the end of treatment at 4 weeks
Likert scale of agreement for cough-related adherence barriers
Timeframe: From enrollment to the end of treatment at 4 weeks
Likert scale of agreement for acceptability
Timeframe: From enrollment to the end of treatment at 4 weeks
Likert scale of agreement for appropriateness
Timeframe: From enrollment to the end of treatment at 4 weeks
Carolyn K. Novaleski, Ph.D., CCC-SLP
Likert scale of agreement for burden
Timeframe: From enrollment to the end of treatment at 4 weeks
Distress Questionnaire-5 (DQ5)
Timeframe: From enrollment to the end of treatment at 4 weeks
Binary scale for monitoring program-specific psychological distress
Timeframe: From enrollment to the end of treatment at 4 weeks
Adverse events (AEs)
Timeframe: From enrollment to the end of treatment at 4 weeks